key: cord-0989472-enwz1d51 authors: Birlutiu, Victoria; Feiereisz, Alin Iulian; Oprinca, George; Dobritoiu, Simona; Rotaru, Maria; Birlutiu, Rares Mircea; Iancu, Gabriela Mariana title: Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - a possible pattern? Observational study and review of the literature date: 2021-04-19 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.04.058 sha: c441daf476390d35ac519d5c743e9d134bf6ef3b doc_id: 989472 cord_uid: enwz1d51 BACKGROUND: The cutaneous manifestations of SARS-CoV-2 have been insufficiently covered in the literature. METHODS: We retrospectively analyzed 39 patients, admitted in our hospital, all with confirmed SARS-CoV-2 infection, patients that associated during the hospitalization or in the convalescence period various skin manifestations. RESULTS: We admitted in our hospital from March 23 until September 12, 2020, 39 cases of SARS-CoV-2 infected patients which were identified with intra-infectious rash or with lesions ofcutaneous vasculitis during convalescence. The most common cutaneous manifestation are erythematous and erythematous papular rash. 27 of the 39 documented patients had anosmia (69.2%), 26 patients had ageusia (66.7%), 34 patients presented pneumonia (87.2%), 24 patients had intra-infectious enterocolitis (61.5%). Skin biopsies were rarely performed in these patients. Furthermore, we are reporting two performed biopsies with the histopathological and immunohistochemistry changes of this selected cases of erythematous rash and erythema multiforme-like lesions. Both skin biopsies reveal an early fibrous remodeling of the dermis, suggesting similar changes that occur in the lungs or in other tissues in this disease. CONCLUSIONS: The correlation of the skin lesions in SARS-CoV-2 infection with anosmia, ageusia and enteritis does not seem to be accidental, but associated with a similar response to ACE2 receptor expression in these tissues. cutaneous vasculitis during convalescence. The most common cutaneous manifestation are erythematous and erythematous papular rash. 27 of the 39 documented patients had anosmia (69.2%), 26 patients had ageusia (66.7%), 34 patients presented pneumonia (87.2%), 24 patients had intra-infectious enterocolitis (61.5%). Skin biopsies were rarely performed in these patients. Furthermore, we are reporting two performed biopsies with the histopathological and immunohistochemistry changes of this selected cases of erythematous rash and erythema multiforme-like lesions. Both skin biopsies reveal an early fibrous remodeling of the dermis, suggesting similar changes that occur in the lungs or in other tissues in this disease. The correlation of the skin lesions in SARS-CoV-2 infection with anosmia, ageusia and enteritis does not seem to be accidental, but associated with a similar response to ACE2 receptor expression in these tissues. Keywords: SARS-CoV-2 infection; COVID-19; cutaneous manifestations; lesions; biopsy. The expression levels of the ACE2 receptors in various human tissues may be responsible for the pathogenesis of SARS-CoV-2 infection. The presence of ACE2 receptors in the respiratory system, cardiovascular system, digestive tract (esophageal mucosa, ileum), kidneys and uroepithelium explains their involvement in the context of SARS-CoV-2 infection. Skin involvement in the severe acute respiratory syndrome coronavirus 2 infection has been clinically and histopathological incompletely studied. The Academic Emergency Hospital Sibiu, Romania, was involved from the beginning in the treatment of SARS-CoV-2 infected patients. With this study, we aimed to evaluate the dermatological aspects and changes found in 39 patients with COVID-19 and the histopathological and immunohistochemistry changes of two selected cases with erythematous rash and erythema multiforme-like lesions. In the initial phase, skin lesions are produced by the direct action of the virus in the epidermis. Direct vascular lesions can be a cause for epidermal manifestations through hematogenous dissemination (lymphocytic thrombophilic arteritis) [1] . Immunological mechanisms can also be a contributive factor by the excess of proinflammatory cytokines or by autoimmune mechanisms, suggested by other studies [2] . In vascular lesions, the SARS-CoV-2 virus stimulates CD4+ T lymphocyte in the production of proinflammatory cytokines (IL-1, IFN-γ, and TNF-α) and recruits eosinophils, CD8+ T lymphocytes, B and NK cells, which target keratinocytes. It is admitted that the expression of ACE2 receptors in the epidermis but also in the digestive cells, cerebral and vascular tissues correlates positively with the level of CD8+ T lymphocytes, interferon, B and NK cells, both in females and males [3] . A single-center observational cohort ongoing study on SARS-CoV-2 infected patients is conducted in the Academic Emergency Hospital Sibiu, Romania, a county hospital with 1054 beds that is dedicated for the treatment of SARS-CoV-2 infected patients. In this study we retrospectively analyzed 39 patients, admitted in our hospital, all with confirmed SARS-CoV-2 infection (by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) from nasal and pharyngeal swabs), patients that associated during the hospitalization period various skin manifestations. Detailed information regarding the enrolled cases was abstracted from the medical records of the patients. All data was available for all the enrolled patients. Written informed J o u r n a l P r e -p r o o f consent was obtained from the patients for publication of their case report and any accompanying images. The study was accepted by the Ethics Committee of the hospital and they encouraged publishing the article. A copy of the written consent is available for review by the Editor-in-Chief of this journal. We admitted in our hospital from March 23, 2020 until September 12, 2020, 39 cases of SARS-CoV-2 infected patients which were identified with intra-infectious rash or with lesions of presuming a correlation between ectoderm-derived cells and the affinity of SARS-CoV-2 for this type of cells. Only in four cases the rash was preceded by fever, the rash being generalized in all of these situations. Two of the cases showed a scarlet fever-like eruption with subsequent furfuraceous desquamation. One case associated during the disease course a syncope. Only two cases of skin lesions occurred after the patients were discharged from the hospital, the lesions had a vasculitis appearance. The rest of the cases were present between the 2nd and 25th day of hospitalization, in 36 cases the SARS-CoV-2 virus has been identified at the time of rash, suggesting its direct action in the epidermis. The identified skin lesions in our COVID-19 patients were: maculopapular eruptions (12 cases), disseminate erythematous rash (12 cases), localized erythematous rash, mainly on trunk skin manifestations during hospitalization and 10 patients after discharge [4] . Skin rashes were found in 14 cases, urticaria in 3 patients and vesicular manifestations in one case. In our study, the rash appeared immediately after the discharge in only two cases, the patients were discharged when viral clearance was achieved (repeated negative RT-PCR swab test for SARS-CoV-2 at 24 h) [5] . The second case presented with left hallux chilblain-like lesions or COVID toes, the rest of the cases were diagnosed during the hospitalization period in parallel with the persistence of the virus in nasal and pharyngeal control swabs. Guan et al, in February 2020, in China reported only 2 cases of skin rash out of the 1099 positive patients for SARS-CoV-2 (0.2%) [6] . In our study, 3.91% of COVID-19 patients had cutaneous manifestations, the most common being erythematous rash and maculopapular eruptions. The French observational study of Bouaziz JD and collaborators captured several aspects of skin lesions: rash, chicken-pox like vesicles, cold urticaria but also petechial rash, livedo, necrotic and non-necrotic purpura, chilblain-like lesions with or without Raynaud's phenomena, and cherry angioma [7] . Annunziata et al. reported 4 cases of erythematous papular rashes and urticarial lesions with an onset after 3 to 9 days from the onset of the COVID-19 respiratory manifestations [8] . Manalo et al. described two cases of livedo reticularis as cutaneous manifestations associated with SARS-CoV-2 infection, secondary to dermal vascular microthrombosis [9] and Jimenez-Cauhe J et al. described a case of petechial rash [10] . Zhang Y et al. described acroischemic lesions in 7 patients, as well as lesions in the context of disseminated intravascular coagulation in 4 critical patients [11] . Moreover, skin lesions were present in three patients with coagulopathy and antiphospholipid antibodies [12] -similar lesions in the limbs are shown in figure no. 7, in the first patient diagnosed in our COVID-19 service. The patient had respiratory distress, multiple organ failure, and disseminated intravascular coagulation. We did not perform the dosing of antiphospholipid antibodies in order to possibly support the double cause of lesions, labeled in the context of disseminated intravascular coagulation. Dertlioğlu SB, presented 5 cases of rash associated with the same pattern that we noticed, anosmia and ageusia, in the presence of SARS-CoV-2 virus in the nasopharyngeal swabs, with the appearance of annular erythema, erythematous or and erythematous papular rash, with spontaneous remission. The rash occurred in young people without comorbidities [13] . Also, in our cases, viral rash associated with anosmia and ageusia occurred in patients with mild to moderate disease forms, who did not require respiratory support. Skin biopsies were rarely performed in these patients, the histological dynamics were present in the evolution of the rash, as well as the various aspects of the lesions that may be associated with COVID-19. Gianotti et al. 14] described the histological changes of two COVID-19 cases. In the first case, a patient with erythematous rash located at the level of the thorax, he highlighted the presence of dyskeratosis cells, associated with ballooned multinucleated cells, necrotic keratinocytes and satellite lymphocyte infiltrate. In the second case, he described the appearance of a diffuse lymphocytic vasculitis with microthrombi. The first case in which we performed a skin biopsy (erythema multiforme-like rash, see [15] presented a case of urticarial rash, which occurred on the 6 th day of hospitalization. The histological examination revealed lymphocytic perivascular infiltrate, eosinophils and dermal edema. ACE2 expression in the digestive tract is higher in the ileal epithelium (approximately 30% of cells are positive for ACE2 receptors) compared to the esophagus (1%), stomach and liver (less than 1%) [16] , explaining the presence of diarrheal stools as the most common digestive manifestation in SARS-CoV-2 infection. In our experience, the rash during hospitalization was most often associated with the digestive episode, suggesting viremia during which SARS-CoV-2 binds to ACE2 receptors in various tissues, as well as possible correlation with CD8+ T lymphocytes, interferon, B and NK cells. Rarely, we found dry mouth or persistent bitter taste described by patients at the onset of the disease or as the disease progressed. The presence of diarrhea with SARS-CoV-2 invasion in the digestive tract, especially in enterocytes [17] [18] [19] [20] [21] associated with the presence of viremia has been described by other authors. The major limitation of our study is the small number of enrolled patients (39 patients with cutaneous manifestation) as well as the low number of performed histopathological examinations of the skin lesions (only 2). The correlation of the skin lesions in SARS-CoV-2 infection with anosmia, ageusia and enteritis does not seem to be accidental, but associated with a similar response to ACE2 receptor expression in these tissues, in direct correlation with the immune response of CD8+ T lymphocytes cells, B and NK cells. Both skin biopsies reveal an early fibrous remodeling of the dermis, suggesting Availability of data and materials All data generated or analyzed during this study are included in this published article. The authors have no conflicts of interest to disclose. The publication of this study was supported by institutional funding (Lucian Blaga University of Sibiu & Hasso Plattner Foundation research grants LBUS-IRG-2020-06). The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Lymphocytic thrombophilic arteritis: a newly described medium-sized vessel arteritis of the skin Skin involvement in SARS-CoV-2 infection: Case series Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues Cutaneous manifestations in COVID-19: a first perspective Viral exanthema as manifestation of SARS-CoV-2 infection: A case report Clinical Characteristics of Coronavirus Disease 2019 in China Vascular skin symptoms in COVID-19: a French observational study Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection COVID-19 can present with a rash and be mistaken for Dengue": petechial rash in a patient with COVID-19 infection Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia Skin manifestations in COVID-19: A case series of five patients from Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies The single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis Angiotensin-converting enzyme 2 is an essential regulator of heart function A protein complex in the brush-border membrane explains a Hartnup disorder allele The publication of this study was supported by institutional funding